BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 22443478)

  • 1. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis.
    Makkar RR; Fontana GP; Jilaihawi H; Kapadia S; Pichard AD; Douglas PS; Thourani VH; Babaliaros VC; Webb JG; Herrmann HC; Bavaria JE; Kodali S; Brown DL; Bowers B; Dewey TM; Svensson LG; Tuzcu M; Moses JW; Williams MR; Siegel RJ; Akin JJ; Anderson WN; Pocock S; Smith CR; Leon MB;
    N Engl J Med; 2012 May; 366(18):1696-704. PubMed ID: 22443478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-year outcomes after transcatheter or surgical aortic-valve replacement.
    Kodali SK; Williams MR; Smith CR; Svensson LG; Webb JG; Makkar RR; Fontana GP; Dewey TM; Thourani VH; Pichard AD; Fischbein M; Szeto WY; Lim S; Greason KL; Teirstein PS; Malaisrie SC; Douglas PS; Hahn RT; Whisenant B; Zajarias A; Wang D; Akin JJ; Anderson WN; Leon MB;
    N Engl J Med; 2012 May; 366(18):1686-95. PubMed ID: 22443479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve).
    Hahn RT; Pibarot P; Webb J; Rodes-Cabau J; Herrmann HC; Williams M; Makkar R; Szeto WY; Main ML; Thourani VH; Tuzcu EM; Kapadia S; Akin J; McAndrew T; Xu K; Leon MB; Kodali SK
    JACC Cardiovasc Interv; 2014 Jul; 7(7):781-9. PubMed ID: 25060022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy.
    Kapadia SR; Tuzcu EM; Makkar RR; Svensson LG; Agarwal S; Kodali S; Fontana GP; Webb JG; Mack M; Thourani VH; Babaliaros VC; Herrmann HC; Szeto W; Pichard AD; Williams MR; Anderson WN; Akin JJ; Miller DC; Smith CR; Leon MB
    Circulation; 2014 Oct; 130(17):1483-92. PubMed ID: 25205802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
    Leon MB; Smith CR; Mack M; Miller DC; Moses JW; Svensson LG; Tuzcu EM; Webb JG; Fontana GP; Makkar RR; Brown DL; Block PC; Guyton RA; Pichard AD; Bavaria JE; Herrmann HC; Douglas PS; Petersen JL; Akin JJ; Anderson WN; Wang D; Pocock S;
    N Engl J Med; 2010 Oct; 363(17):1597-607. PubMed ID: 20961243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.
    Kapadia SR; Leon MB; Makkar RR; Tuzcu EM; Svensson LG; Kodali S; Webb JG; Mack MJ; Douglas PS; Thourani VH; Babaliaros VC; Herrmann HC; Szeto WY; Pichard AD; Williams MR; Fontana GP; Miller DC; Anderson WN; Akin JJ; Davidson MJ; Smith CR;
    Lancet; 2015 Jun; 385(9986):2485-91. PubMed ID: 25788231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.
    Mack MJ; Leon MB; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Pibarot P; Leipsic J; Hahn RT; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Genereux P; Pershad A; Pocock SJ; Alu MC; Webb JG; Smith CR;
    N Engl J Med; 2019 May; 380(18):1695-1705. PubMed ID: 30883058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical sutureless and transcatheter aortic valves: hemodynamic performance and clinical outcomes in propensity score-matched high-risk populations with severe aortic stenosis.
    Kamperidis V; van Rosendael PJ; de Weger A; Katsanos S; Regeer M; van der Kley F; Mertens B; Sianos G; Ajmone Marsan N; Bax JJ; Delgado V
    JACC Cardiovasc Interv; 2015 Apr; 8(5):670-7. PubMed ID: 25946438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter versus surgical aortic-valve replacement in high-risk patients.
    Smith CR; Leon MB; Mack MJ; Miller DC; Moses JW; Svensson LG; Tuzcu EM; Webb JG; Fontana GP; Makkar RR; Williams M; Dewey T; Kapadia S; Babaliaros V; Thourani VH; Corso P; Pichard AD; Bavaria JE; Herrmann HC; Akin JJ; Anderson WN; Wang D; Pocock SJ;
    N Engl J Med; 2011 Jun; 364(23):2187-98. PubMed ID: 21639811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement.
    Makkar RR; Thourani VH; Mack MJ; Kodali SK; Kapadia S; Webb JG; Yoon SH; Trento A; Svensson LG; Herrmann HC; Szeto WY; Miller DC; Satler L; Cohen DJ; Dewey TM; Babaliaros V; Williams MR; Kereiakes DJ; Zajarias A; Greason KL; Whisenant BK; Hodson RW; Brown DL; Fearon WF; Russo MJ; Pibarot P; Hahn RT; Jaber WA; Rogers E; Xu K; Wheeler J; Alu MC; Smith CR; Leon MB;
    N Engl J Med; 2020 Feb; 382(9):799-809. PubMed ID: 31995682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes and revascularization strategies in patients with low-flow, low-gradient severe aortic valve stenosis according to the assigned treatment modality.
    O'Sullivan CJ; Englberger L; Hosek N; Heg D; Cao D; Stefanini GG; Stortecky S; Gloekler S; Spitzer E; Tüller D; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Carrel T; Meier B; Windecker S; Wenaweser P
    JACC Cardiovasc Interv; 2015 Apr; 8(5):704-17. PubMed ID: 25946444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Importance of Diastolic Dysfunction in Relation to Post Procedural Aortic Insufficiency in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kampaktsis PN; Bang CN; Chiu Wong S; Skubas NJ; Singh H; Voudris K; Baduashvili A; Pastella K; Swaminathan RV; Kaple RK; Minutello RM; Feldman DN; Kim L; Hriljac I; Lin F; Bergman GS; Salemi A; Devereux RB
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):445-451. PubMed ID: 27218599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of periprocedural and mid-term stroke rates and outcomes between surgical aortic valve replacement and transcatheter aortic valve replacement patients.
    Aalaei-Andabili SH; Anderson RD; Petersen JW; Beaver TM; Bavry AA; Klodell CT
    J Cardiovasc Surg (Torino); 2017 Aug; 58(4):591-597. PubMed ID: 27078127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.